GG 705 (Ranitidine 150 mg)

Pill imprint GG 705 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; gastric ulcer maintenance treatment; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GG 705 (Ranitidine 150 mg)

Ranitidine hydrochloride 150 mg GG 705  Front
Ranitidine hydrochloride 150 mg GG 705  Back
Ranitidine hydrochloride 150 mg GG 705
Ranitidine hydrochloride
GG 705
150 mg
8.00 mm
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
D&C Red No. 30
hydroxypropyl cellulose
hypromellose 2910 (3 mPa.s)
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
titanium dioxide
triethyl citrate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0879 UDL Laboratories Inc
63739-0266 McKesson Packaging Services
66267-0188 Nucare Pharmaceuticals Inc (repackager)
57866-6930 Direct Dispensing Inc (repackager)
67544-0049 Prepak Systems Inc (repackager)
21695-0109 Rebel Distributors Corp (repackager)
23490-6249 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)